Profile data is unavailable for this security.
About the company
Satellos Bioscience Inc. is a Canada-based a drug discovery and development company with a focus on muscle regeneration. The Company is focused on developing medicines to treat degenerative muscle conditions. Its MyoReGenX platform is specifically designed to recreate the specialized muscle stem cell niche in vitro. MyoReGenX platform enables to map pathways which modulate muscle repair and regeneration, identify, and confirm drug targets, and test drug candidates for their ability to restore muscle stem cell repair mechanisms that have been impaired by genetic mutations, disease or injury. Its lead program is an oral, small molecule drug candidate in development as a disease-modifying treatment for Duchenne muscular dystrophy. Its iCo portfolio includes Oral Amp B Delivery System, a patented oral transport technology and Bertilimumab a human monoclonal eotaxin antibody with potential to treat a range of allergic and inflammatory conditions mediated by eotaxin-1.
- Revenue in CAD (TTM)0.00
- Net income in CAD-21.13m
- Incorporated2021
- Employees12.00
- LocationSatellos Bioscience Inc200 Bay Street, Suite 2800TORONTO M5J 2J1CanadaCAN
- Phone+1 (647) 660-1780
- Websitehttps://satellos.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Decibel Cannabis Company Inc | 115.96m | -1.77m | 41.03m | -- | -- | 0.8854 | 30.62 | 0.3538 | -0.0045 | -0.0045 | 0.2739 | 0.1129 | 0.817 | 1.51 | 7.66 | -- | -1.25 | -3.55 | -2.04 | -5.19 | 36.10 | 38.83 | -1.53 | -7.13 | 0.3685 | 1.21 | 0.5122 | -- | 46.18 | -- | 60.33 | -- | -32.45 | -- |
| IntelGenx Technologies Corp. | 1.44m | -15.10m | 41.92m | 48.00 | -- | -- | -- | 29.13 | -0.0865 | -0.0865 | 0.0082 | -0.1205 | 0.1245 | 14.36 | 1.74 | -- | -130.62 | -75.15 | -- | -133.79 | -66.03 | -- | -1,049.48 | -819.85 | 0.1153 | -4.88 | 23.66 | -- | 9.37 | -10.65 | 7.14 | -- | -30.32 | -- |
| Immunoprecise Antibodies Ltd | 23.68m | -14.26m | 42.17m | 102.00 | -- | 0.8463 | -- | 1.78 | -0.4134 | -0.4134 | 0.6853 | 1.38 | 0.2939 | 5.25 | 6.76 | 169,537.00 | -17.70 | -23.62 | -19.62 | -27.25 | 51.88 | 57.18 | -60.23 | -76.18 | 1.38 | -- | 0.2241 | -- | 6.72 | 30.59 | -58.96 | -- | 34.04 | -- |
| Microbix Biosystems Inc | 23.84m | 4.06m | 44.79m | 69.00 | 10.99 | 1.61 | 8.20 | 1.88 | 0.0296 | 0.0296 | 0.173 | 0.202 | 0.6703 | 1.67 | 6.33 | -- | 11.42 | -0.9729 | 12.72 | -1.17 | 54.38 | 52.30 | 17.04 | -1.55 | 4.98 | 3.53 | 0.1948 | -- | -13.43 | 5.71 | -102.21 | -- | -3.56 | -- |
| MustGrow Biologics Corp | 4.71m | -676.95k | 47.32m | 0.00 | -- | 8.76 | -- | 10.04 | -0.0144 | -0.0144 | 0.0944 | 0.1085 | 0.6697 | -- | 51.61 | -- | -9.62 | -50.41 | -11.96 | -59.28 | -- | -- | -14.37 | -298.73 | -- | -- | 0.1197 | -- | 72,619.13 | 372.54 | 87.84 | -- | -- | -- |
| Helix Biopharma Corp. | 0.00 | -5.65m | 48.33m | 9.00 | -- | -- | -- | -- | -0.0277 | -0.0277 | 0.00 | -0.0012 | 0.00 | -- | -- | 0.00 | -318.95 | -261.49 | -574.76 | -- | -- | -- | -- | -- | -- | -2,825.00 | -- | -- | -- | -- | 4.16 | -- | -28.36 | -- |
| LSL Pharma Group Inc | 10.03m | -8.47m | 49.94m | -- | -- | 4.38 | -- | 4.98 | -0.1117 | -0.1117 | 0.1264 | 0.105 | -- | -- | -- | -- | -- | -- | -- | -- | 16.40 | -- | -84.48 | -- | 0.2053 | -1.14 | 0.6527 | -- | -- | -- | -- | -- | -- | -- |
| Satellos Bioscience Inc | 0.00 | -21.13m | 53.17m | 12.00 | -- | 1.54 | -- | -- | -0.1718 | -0.1718 | 0.00 | 0.3059 | 0.00 | -- | -- | 0.00 | -93.29 | -107.22 | -109.86 | -136.58 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -40.33 | -- | 459.46 | -- |
| Auxly Cannabis Group Inc | 102.35m | -60.27m | 62.76m | 369.00 | -- | 0.6012 | -- | 0.6131 | -0.0596 | -0.0596 | 0.1017 | 0.0832 | 0.3454 | 2.26 | 5.92 | 277,374.00 | -20.34 | -21.47 | -30.18 | -24.99 | 7.93 | 5.08 | -58.89 | -124.15 | 0.3836 | -1.40 | 0.4399 | -- | 6.99 | 166.85 | 65.84 | -- | -40.92 | -- |
| Medmira Inc | 407.78k | -2.92m | 63.65m | 65.00 | -- | -- | -- | 156.08 | -0.0042 | -0.0042 | 0.0006 | -0.0229 | 0.0996 | 0.7899 | 0.3142 | -- | -71.41 | -69.95 | -- | -- | 61.54 | 66.76 | -717.02 | -187.61 | 0.1342 | -2.09 | -- | -- | -54.57 | -5.98 | -46.08 | -- | -- | -- |
| KDA Group Inc | 186.28k | 133.66k | 66.85m | -- | 189.05 | 4.29 | 76.52 | 358.88 | 0.002 | 0.0926 | 0.0012 | 0.0886 | 0.0079 | -- | 0.0693 | -- | -0.4146 | -17.96 | -0.8534 | -44.69 | 36.51 | 26.76 | -52.24 | -28.00 | -- | -4.31 | 0.1287 | -- | -22.20 | -62.03 | 106.88 | -- | 31.67 | -- |
